MD Financial Management’s Pfizer PFE Stock Holding History

MD Financial Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.07M	Buy	18,071 +3,431	+23%	+$170K	0.03%	250
2021 Q3	$630K	Buy	14,640 +2,827	+24%	+$125K	0.02%	259
2021 Q2	$463K	Sell	11,813 -42,474	-78%	-$1.65M	0.01%	254
2021 Q1	$1.97M	Buy	54,287 +52,287	+2,614%	+$1.86M	0.06%	119
2020 Q4	$74K	Buy	+2,000	New	+$73.4K	﹤0.01%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MD Financial Management's PFE Position: Q4 2021 in Review

MD Financial Management increased its Pfizer (PFE) stake by 23% in Q4 2021, buying an estimated $170K and bringing the position to 18,071 shares worth $1.07M. The position accounts for 0.03% of the portfolio, ranked #250.

MD Financial Management first reported a position in PFE in Q4 2020 and has held it in 5 quarters since. The position peaked at $1.97M in Q1 2021. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

MD Financial Management held 18,071 shares of Pfizer worth $1.07M as of Q4 2021.
MD Financial Management bought 3,431 Pfizer shares in Q4 2021, an estimated $170K.
Pfizer made up 0.03% of MD Financial Management's portfolio in Q4 2021, its #250 holding.
MD Financial Management first reported a position in Pfizer in Q4 2020 and has held it in 5 quarters since.
MD Financial Management's Pfizer position peaked at $1.97M in Q1 2021.
3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.